FIGURE 3.
Best overall response by PD-L1. ORR data by race/ethnic group for patients with NSCLC treated with ICI monotherapy stratified by PD-L1 e50% (A), 1%–49% (B), and 0% (C). PR, partial response; SD, stable disease; PD, progressive disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.